Sheremet, A. B.
Nesterenko, L. N.
Zigangirova, N. A.
Article History
Received: 3 June 2019
Revised: 8 July 2019
Accepted: 10 July 2019
First Online: 13 June 2020
COMPLIANCE WITH ETHICAL STANDARDS
: The authors declare that they have no conflict of interest. This article does not contain any studies involving animals or human participants performed by any of the authors.
: Sheremet A.B., е-mail: anna-pimenova@mail.ru; ExternalRef removedNesterenko L.N., е-mail: nesterenko.mila@gmail.com; ExternalRef removedZigangirova N.A., е-mail: zigangirova@mail.ru; ExternalRef removedCorresponding author: Sheremet A. B., е-mail: anna-pimenova@mail.ruTo cite this article:Sheremet A.B., Nesterenko L.N., Zigangirova N.A. “The <i>Pseudomonas aeruginosa</i> Type-Three Secretion System as a Target for Development of Antivirulence Drugs.” <i>Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya</i> (<i>Molecular Genetics, Microbiology, and Virology</i>), 2020, vol. 38, no. 1, pp. 3–14 (Russian). ExternalRef removed